Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05114187
Other study ID # #21-24
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 6, 2022
Est. completion date September 5, 2023

Study information

Verified date October 2023
Source McMaster University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

With the aging population, the prevalence of dementia is increasing dramatically. People living with dementia are highly dependent on family care partners, who may have little knowledge of the disorder. National and provincial guidelines have all highlighted the importance of online resources to improve care partner education; however, very few have been widely implemented or rigorously studied. The investigators have developed the award-winning dementia education platform to complement traditional patient and family educational approaches. It allows free access to multimedia e-learning lessons, live expert webinars, and email-based content that care partners can access any time, anywhere. In a pilot randomized controlled trial (RCT), the investigators propose to study 1) the feasibility and care partner acceptance of the intervention and some of the study methods, and 2) the impact of the intervention on care partner self-efficacy, knowledge, and sense of burden. This initiative has the potential to improve the quality, cost effectiveness, and efficiency of dementia care. The intervention could be easily scaled and spread both provincially and nationally to complement other dementia education methods, at a time when the prevalence of dementia is increasing and access to high quality internet-based interventions is essential.


Recruitment information / eligibility

Status Completed
Enrollment 125
Est. completion date September 5, 2023
Est. primary completion date September 5, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. they are a family and/or friend care partner of a person living with dementia, 2. they reside in Canada, 3. they are 18 years of age and over, 4. they have a good command of the English language, 5. they have access to email and internet, 6. they are comfortable using email and internet, 7. they have the ability to grant online informed consent, and 8. they complete online baseline assessments. Exclusion Criteria: 1. they are a not family and/or friend care partner of a person living with dementia, 2. they do not reside in Canada, 3. they are not 18 years of age and over, 4. they do not have a good command of the English language, 5. they do not have access to email and internet, 6. they are not comfortable using email and internet, 7. they do not have the ability to grant online informed consent, and 8. they do not complete online baseline assessments.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Education Intervention
Participants in the intervention group will be provided e-learning about dementia and promoting brain health, consisting of the following components: Ten selected multimedia e-learning lessons; A series of 16 'micro-learning' emails (2 emails/week) with small segments of content to reinforce the material from the lessons. Participants will have 8-weeks to complete the intervention. The total time to complete is approximately 5-6 hours.
Education Control
Participants in the control group will be provided e-learning about dementia and promoting brain health, consisting of the following components: One selected multimedia e-learning lesson; A series of 16 'micro-learning' emails (2 emails/week) with small segments of content to reinforce the material from the lessons. Participants will have 8-weeks to complete. The total time to complete is approximately 1-2 hours. Note: All participants will receive access to all e-learning at the conclusion of the study.

Locations

Country Name City State
Canada McMaster University Hamilton Ontario

Sponsors (2)

Lead Sponsor Collaborator
McMaster University The Physicians' Services Incorporated Foundation

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Intervention adherence (time spent) Lesson completed data and email open rates will be collected and saved to quantify the time(s) spent on intervention activities. 8 weeks
Primary Participant satisfaction A custom satisfaction questionnaire data adapted from the Information Assessment Method For All (IAM4all) will be collected and saved to assess satisfaction with the intervention. 8 weeks
Primary Participant satisfaction A custom implementation oral interview questionnaire adapted from The Consolidated Framework for Implementation Research (CFIR) will be collected and saved to assess implementation of the intervention. 8 weeks
Secondary Recruitment rates Participant recruitment numbers will be collected and saved to quantify the number of interested participants. 8 weeks
Secondary Attrition rates Participant attrition rates will be collected and saved to quantify the number of study dropouts vs completions 8 weeks
Secondary Change from baseline in the Revised Scale for Caregiving Self-Efficacy (RSCSE) at 8 weeks. Self-efficacy will be measured through the Revised Scale for Caregiving Self-Efficacy (RSCSE) (reliability a = >.80). The RSCSE contains 15 items within 3 subscales (self-efficacy for obtaining respite, responding to disruptive patient behaviours, and controlling upsetting thoughts about caregiving). Higher scores indicate a higher level of self-efficacy. 0, 8 weeks
Secondary Change from baseline in the Dementia Knowledge Assessment Scale (DKAS) at 8 weeks. Knowledge will be measured through the Dementia Knowledge Assessment Scale (DKAS) (reliability a = .85; ?h = .87; overall scale). The DKAS consists of 25 items on different aspects of dementia that could be answered with 'True,' 'Probably True,' 'False, 'Probably False,' or 'I don't know.' Higher scores indicate a higher level of dementia knowledge. 0, 8 weeks
Secondary Change from baseline in the Zarit Burden Interview (ZBI) at 8 weeks. Burden will be measured through the Zarit Burden Interview (ZBI) (reliability a = .92). The ZBI contains 22 items. Each item on the interview is a statement which the caregiver is asked to endorse using a 5-point scale. Response options range from 0 (Never) to 4 (Nearly Always). Higher scores indicate a higher level of burden. 0, 8 weeks
See also
  Status Clinical Trial Phase
Completed NCT05686486 - Gentle Gymnastics and Relationship Between Family Caregivers and Residents With Dementia in Nursing Homes N/A
Terminated NCT05451693 - Outreach-ER: A Dementia Care Intervention Program
Recruiting NCT05820919 - Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase N/A
Enrolling by invitation NCT06040294 - Dementia and Disability Simulation for College Nursing Students' Senior Activity Facilitation Skills N/A
Recruiting NCT06322121 - Vascular Aspects in Dementia: Part 2
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT04426838 - Cognitive Behavioral Therapy for Insomnia for the Dementia Caregiving Dyad N/A
Recruiting NCT03462485 - Pilot Study of the Effects of Playing Golf on People With Dementia N/A
Active, not recruiting NCT03677284 - Managing Time With Dementia: Effects of Time Assistive Products in People With Dementia N/A
Completed NCT03849937 - Changing Talk Online (CHATO) Study N/A
Recruiting NCT06284213 - Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium
Recruiting NCT05579236 - Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT05080777 - Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems N/A
Completed NCT04571697 - A Study of Comparing Rates of Dementia and Alzheimer's Disease in Participants Initiating Methotrexate Versus Those Initiating Anti-tumor Necrosis Factor (TNF)-Alpha Therapy
Completed NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Recruiting NCT06033066 - Financial Incentives and Recruitment to the APT Webstudy N/A
Active, not recruiting NCT05204940 - Longitudinal Observational Biomarker Study
Recruiting NCT05684783 - Dementia Champions in Homecare
Completed NCT03147222 - Function Focused Care: Fracture Care at Home N/A
Enrolling by invitation NCT04675229 - Extending the Validation of SCREEN to Persons Living With Dementia or in Retirement Homes